MH6: COST-UTILITY ANALYSIS OF RISPERIDONE IN CHRONIC SCHIZOPHRENIA
نویسندگان
چکیده
منابع مشابه
Utility Estimation of Health Status of Cancer Patients by Mapping for Cost-Utility Analysis
Background: It is important to obtain accurate information about the preferences of people for measuring quality-adjusted life years (QALYs), because it is necessary for cost-utility analysis. In this regard, mapping is a method to access this information. Therefore, the purpose of this study was to map Functional Assessment of Cancer Therapy – General (FACT-G) onto Short Form Six Dimension (SF...
متن کاملTeriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis in Iran
Background: Teriparatide is a new agent serves as a treatment of choice for severe post-menopausal osteoporotic patients who are at a high risk of fracture or have failed or been intolerant of previous osteoporosis therapy. The objective of this study is estimating the cost-utility of Teriparatide compared with no treatment from health system perspective in Iran. Method: A microsimulation...
متن کاملRisperidone in Schizophrenia
Efficacy and safety of new antipsychotic agent-risperidone was evaluated in the confirmed schizophrenic patients of either sex, over 15 years of age. Of the 30 patients who entered the study, 27 completed the trial as per the protocol and only 3 dropped out, one was lost to follow up, the other was an uncooperative patient who pulled out of the trial due to moderate side effects while one patie...
متن کاملRisperidone in Schizophrenia
Dear Sir, It was of interest to read the case report on musical obsessions (Journal 1999, 41,77-78). The clinical picture, especially the phenomenon of a particular set of known musical notes repeatedly being perceived resembles Palinacousis. This phenomenon was descnbed by Jacob and associates in 1973 as persistent or recurring paroxysmal auditory illusions in which enviornmentally produced au...
متن کاملCost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia.
OBJECTIVE The effect of long-acting injectable (LAI) risperidone on health care costs was determined in a multisite clinical trial. METHOD Veterans Health Administration patients with unstable schizophrenia or schizoaffective disorder established by the Structured Clinical Interview for DSM-IV (N = 369) were randomized between 2006 and 2009 to long-acting risperidone or physician's choice of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 1999
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(11)70082-1